Pneumococcal Immunization Reduces Neurological and Hepatic Symptoms in a Mouse Model for Niemann-Pick Type C1 Disease
Niemann-Pick type C1 (NPC1) disease is caused by a deleterious mutation in the Npc1 gene, causing lysosomal accumulation of unesterified cholesterol and sphingolipids. Consequently, NPC1 disease patients suffer from severe neurovisceral symptoms which, in the absence of effective treatments, result...
Main Authors: | Tom Houben, Inês Magro dos Reis, Yvonne Oligschlaeger, Hellen Steinbusch, Marion J. J. Gijbels, Tim Hendrikx, Christoph J. Binder, David Cassiman, Marit Westerterp, Jos Prickaerts, Ronit Shiri-Sverdlov |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.03089/full |
Similar Items
-
Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann–Pick diseases
by: Mark L. Schultz, et al.
Published: (2019-11-01) -
Anesthetic consideration of Niemann-Pick Disease type C
by: Masoud Nashibi, et al.
Published: (2016-03-01) -
Localization of the murine Niemann-Pick C1 protein to two distinct intracellular compartments
by: William S. Garver, et al.
Published: (2000-05-01) -
Altered vitamin E status in Niemann-Pick type C disease
by: L. Ulatowski, et al.
Published: (2011-07-01) -
Compound heterozygous Niemann-Pick Type C disease in the neonatal period
by: Deniz Anuk-ince, et al.
Published: (2021-05-01)